osudhkosh

Linatab M 5002.5mg+500mg

Rx
Dosage form:
Tablet
Pack size:
Strip (10 Tablet)
Save to my medicines
Alert me on price drop

৳ 12/unit

Pack: ৳ 120

Price comparison

This brand
12
Cheapest of this genericLinatin M 500
7

The cheaper brand costs ৳ 5.00 less per unit

Compared against 30 brands

At a glance

Linagliptin + Metformin Hydrochloride is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. It reduces glucose production, increases insulin sensitivity, and enhances incretin hormone activity.

Indications
  • Type 2 diabetes mellitus - as an adjunct to diet and exercise to improve glycemic control
Dosage

Immediate Release Tablets:

  • Not currently taking metformin: 2.5 mg/500 mg twice daily
  • Already taking metformin: 2.5 mg linagliptin with current metformin dose twice daily
  • Maximum dose: 2.5 mg/1,000 mg twice daily

Extended Release Tablets:

  • Not currently taking metformin: 5 mg/1,000 mg once daily
  • Already taking metformin: 5 mg linagliptin + equivalent metformin dose once daily
  • Maximum daily dose: Linagliptin 5 mg + Metformin 2,000 mg
Side effects

Common Side Effects:

  • Diarrhea
  • Nausea
  • Vomiting
  • Upset stomach
  • Headache
  • Nasal congestion
  • Sore throat
  • Respiratory tract infection
  • Hypoglycemia (with insulin or sulfonylurea)
Precautions & warnings
  • Inform doctor immediately if symptoms of lactic acidosis occur (deep/rapid breathing, persistent nausea, vomiting, stomach pain)
  • Monitor blood sugar regularly to avoid hypoglycemia
  • Avoid alcohol (risk of hypoglycemia and lactic acidosis)
  • Temporarily stop before major surgery or contrast dye procedures
  • Monitor liver and kidney function regularly
Linagliptin + Metformin Hydrochloride — see the full informationPharmacology, precautions, pregnancy, overdose and the rest on the generic page
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.